Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma
Cancer Letters · 2027-01 · 664 · 218958
DOI: 10.1016/j.canlet.2026.218958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2027-01. Verfasst von Xin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical …. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Metabolic plasticity enables tumors to adapt to fluctuating nutrient environments, yet the non-canonical functions of metabolic enzymes under stress remain largely unexplored. Here, we established a pyrimidine biosynthesis-associated gene score (PBAGS) that predicts survival in esophageal squamous cell carcinoma (ESCC) and identified dihydroorotate dehydrogenase (DHODH) as a critical driver with a context-dependent dual role. Under glucose-replete conditions, DHODH functions as a canonical oncogene, promoting pyrimidine and cysteine metabolism, alongside UDP-GlcNAc production; accordingly, its inhibition by leflunomide suppresses tumor growth. Strikingly, under glucose starvation, DHODH undergoes a functional switch to become a "molecular executioner." Mechanistically, starvation triggers the DHODH-OGT axis to maintain site-specific O-GlcNAcylation of SLC7A11 at Ser26, thereby stabilizing SLC7A11. This modification promotes excessive cystine accumulation and subsequent actin cytoskeleton collapse, ultimately triggering disulfidptosis. Accordingly, inhibition of DHODH abolishes this modification and rescues cells from starvation-induced death. Clinically, DHODH-SLC7A11 axis correlates tightly with GLUT1 expression. Mimicking glucose starvation using GLUT1 inhibitor BAY-876 significantly enhances radiosensitivity in ESCC PDX models that harbor high DHODH/SLC7A11 expression. Collectively, our findings uncover that under glucose starvation, DHODH and SLC7A11 co-dependency synergistically promotes disulfidptosis, suggesting that targeting the metabolic context offers a potent strategy to sensitize ESCC to radiotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China. Electronic address: jiyl@zjcc.org.cn.
- State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Ele…
Zitieren
APA
Li, X., Wu, Y., Lu, M., Gao, W., Lu, M., Zhu, Y., Ji, Y., Liu, Z., & Luo, A. (2027). Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma. Cancer Letters, 664, 218958. https://doi.org/10.1016/j.canlet.2026.218958
Vancouver
Li X, Wu Y, Lu M, Gao W, Lu M, Zhu Y, et al. Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma. Cancer Letters. 2027;664:218958. doi:10.1016/j.canlet.2026.218958
BibTeX
@article{Li2027,
author = {Li, Xin and Wu, Yenan and Lu, Minyi and Gao, Wenyan and Lu, Mengmeng and Zhu, Yaoyi and Ji, Yongling and Liu, Zhihua and Luo, Aiping},
title = {Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma},
journal = {Cancer Letters},
year = {2027},
volume = {664},
pages = {218958},
doi = {10.1016/j.canlet.2026.218958}
}
EUVIMED